Home
Who We Are
Who We Are: Leading Life Science Innovation
At MGI, we are at the forefront of biotechnological innovation, specializing in next-generation sequencing (NGS), laboratory automation and multi-omics platforms that drive advancements in life sciences. We focus on the research, development, production, and sales of cutting-edge equipment, instruments, and reagents, empowering research across fields such as precision medicine, agriculture, and healthcare. Our proprietary technologies, including our core development - the DNBSEQ™ sequencing platforms, deliver unmatched accuracy, high throughput, and minimized amplification bias, providing comprehensive, real-time solutions that revolutionize genetic analysis.
Our Global Presence: A Network of Innovation
Founded in 2016, MGI is dedicated to advancing life sciences with cutting-edge NGS technologies, medical imaging, and laboratory automation. With a global presence in over 100 countries and a team of 2,900 employees, MGI provides high-quality, cost-effective tools to support precision applications in genomics research, delivering innovative solutions that meet the evolving needs of the biotech industry.
We operate in 100+ countries
2.9k customers
Global service network
Our Contributions: Advancing Scientific Discovery
MGI is renowned for its leadership in gene sequencing, evidenced by our extensive range of genetic sequencers and our significant contributions to large-scale cohort study projects. Our technologies have facilitated over 6200 high-impact scientific publications, demonstrating our pivotal role in advancing life science research. Furthermore, our automated sample processing systems have been instrumental in enhancing COVID-19 testing capabilities worldwide, showcasing our commitment to addressing global health challenges.
Vision
Leading Life Science Innovation
Mission
To Develop and Promote Advanced Life Science Tools for Future Healthcare
Our Vision: Building a Cooperative Ecosystem
We advocate for an open, cooperative industry ecosystem, fostering synergy and innovation with our partners. Through initiatives like the Global Sequencer User Program, we aim to create a win-win situation for all stakeholders in the life science industry, emphasizing ethical standards and data privacy.
Our Innovations: Shaping the Future of Healthcare
MGI's relentless pursuit of innovation has led to the development of key technologies in gene sequencing, library preparation, and laboratory automation. With over 736 international patents, our comprehensive portfolio of patented technologies underpins our industry-leading position in digital life science.
